Morgan Stanley Eargo, Inc. Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.73 $20,163 - $30,039	41,150 Added 159.55%	66,942 $38,000
Q3 2022 Nov 14, 2022	SELL	$0.7 - $3.0 $29,045 - $124,479	-41,493 Reduced 61.67%	25,792 $27,000
Q2 2022 Oct 27, 2022	BUY	$0.75 - $5.6 $25,976 - $193,956	34,635 Added 106.08%	67,285 $50,000
Q2 2022 Aug 15, 2022	BUY	$0.75 - $5.6 $25,976 - $193,956	34,635 Added 106.08%	67,285 $50,000
Q1 2022 Oct 27, 2022	SELL	$3.3 - $7.28 $114,295 - $252,142	-34,635 Reduced 51.48%	32,650 $172,000
Q1 2022 May 13, 2022	SELL	$3.3 - $7.28 $555,119 - $1.22 Million	-168,218 Reduced 83.75%	32,650 $172,000
Q4 2021 Feb 14, 2022	BUY	$4.6 - $10.21 $228,399 - $506,946	49,652 Added 32.84%	200,868 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$6.59 - $38.71 $996,513 - $5.85 Million	151,216 New	151,216 $1.02 Million

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.